Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Ovarian clear cell adenocarcinoma

HOXA10 is Overexpressed in Human Ovarian Clear Cell Adenocarcinoma and Correlates With Poor Survival
Bin Li, Hongyan Jin, Yinhua Yu, Chao Gu, Xianrong Zhou, Naiqing Zhao, Youji Feng

International Journal of Gynecologic Cancer Nov 2009, 19 (8) 1347-1352; DOI: 10.1111/IGC.0b013e3181a83f1d
Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma
J. A. Rauh-Hain, R. T. Penson

International Journal of Gynecologic Cancer Aug 2008, 18 (5) 934-936; DOI: 10.1111/j.1525-1438.2007.01156.x